Swiss National Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $469M | Buy |
16,686,212
+1,106,200
| +7% | +$29.5M | 0.27% | 59 |
|
|
2025
Q4 | $388M | Sell |
15,580,012
-808,500
| -5% | -$20.4M | 0.23% | 69 |
|
|
2025
Q3 | $418M | Sell |
16,388,512
-779,500
| -5% | -$19.2M | 0.24% | 67 |
|
|
2025
Q2 | $416M | Buy |
17,168,012
+1,185,000
| +7% | +$27.6M | 0.25% | 67 |
|
|
2025
Q1 | $405M | Sell |
15,983,012
-25,300
| -0.2% | -$662K | 0.29% | 56 |
|
|
2024
Q4 | $425M | Sell |
16,008,312
-811,400
| -5% | -$22M | 0.28% | 53 |
|
|
2024
Q3 | $487M | Buy |
16,819,712
+100,900
| +0.6% | +$2.94M | 0.32% | 52 |
|
|
2024
Q2 | $468M | Sell |
16,718,812
-191,000
| -1% | -$5.26M | 0.32% | 49 |
|
|
2024
Q1 | $469M | Sell |
16,909,812
-744,900
| -4% | -$20.7M | 0.33% | 49 |
|
|
2023
Q4 | $508M | Sell |
17,654,712
-503,300
| -3% | -$15.2M | 0.37% | 41 |
|
|
2023
Q3 | $602M | Sell |
18,158,012
-2,227,700
| -11% | -$78.8M | 0.47% | 32 |
|
|
2023
Q2 | $748M | Sell |
20,385,712
-1,891,400
| -8% | -$73.6M | 0.51% | 30 |
|
|
2023
Q1 | $909M | Sell |
22,277,112
-533,000
| -2% | -$23M | 0.62% | 23 |
|
|
2022
Q4 | $1.17B | Sell |
22,810,112
-1,506,129
| -6% | -$72.2M | 0.84% | 17 |
|
|
2022
Q3 | $1.06B | Sell |
24,316,241
-77,200
| -0.3% | -$3.75M | 0.76% | 18 |
|
|
2022
Q2 | $1.28B | Buy |
24,393,441
+82,500
| +0.3% | +$4.2M | 0.87% | 14 |
|
|
2022
Q1 | $1.26B | Buy |
24,310,941
+3,000,100
| +14% | +$156M | 0.71% | 17 |
|
|
2021
Q4 | $1.26B | Sell |
21,310,841
-822,500
| -4% | -$40.8M | 0.76% | 14 |
|
|
2021
Q3 | $952M | Sell |
22,133,341
-610,000
| -3% | -$27M | 0.61% | 22 |
|
|
2021
Q2 | $891M | Sell |
22,743,341
-161,250
| -0.7% | -$6.27M | 0.55% | 27 |
|
|
2021
Q1 | $830M | Buy |
22,904,591
+409,200
| +2% | +$14.5M | 0.55% | 30 |
|
|
2020
Q4 | $828M | Sell |
22,495,391
-1,853,054
| -8% | -$68M | 0.59% | 27 |
|
|
2020
Q3 | $848M | Sell |
24,348,445
-278,993
| -1% | -$9.78M | 0.66% | 28 |
|
|
2020
Q2 | $764M | Buy |
24,627,438
+345,079
| +1% | +$11.7M | 0.65% | 27 |
|
|
2020
Q1 | $752M | Buy |
24,282,359
+4,200,190
| +21% | +$143M | 0.8% | 20 |
|
|
2019
Q4 | $747M | Sell |
20,082,169
-1,087,728
| -5% | -$38.7M | 0.77% | 21 |
|
|
2019
Q3 | $722M | Buy |
21,169,897
+145,138
| +0.7% | +$5.28M | 0.77% | 22 |
|
|
2019
Q2 | $864M | Sell |
21,024,759
-1,311,703
| -6% | -$52.1M | 0.93% | 13 |
|
|
2019
Q1 | $900M | Buy |
22,336,462
+306,187
| +1% | +$12.3M | 0.99% | 12 |
|
|
2018
Q4 | $912M | Buy |
22,030,275
+362,682
| +2% | +$15.1M | 1.17% | 9 |
|
|
2018
Q3 | $906M | Sell |
21,667,593
-1,123,459
| -5% | -$43.2M | 1.01% | 11 |
|
|
2018
Q2 | $784M | Buy |
22,791,052
+601,096
| +3% | +$20.5M | 0.9% | 15 |
|
|
2018
Q1 | $747M | Sell |
22,189,956
-2,733,443
| -11% | -$94M | 0.91% | 12 |
|
|
2017
Q4 | $856M | Buy |
24,923,399
+14,334
| +0.1% | +$489K | 0.93% | 15 |
|
|
2017
Q3 | $844M | Buy |
24,909,065
+279,521
| +1% | +$8.98M | 0.96% | 11 |
|
|
2017
Q2 | $785M | Buy |
24,629,544
+312,932
| +1% | +$9.87M | 0.93% | 12 |
|
|
2017
Q1 | $789M | Buy |
24,316,612
+4,957,700
| +26% | +$156M | 0.98% | 13 |
|
|
2016
Q4 | $597M | Buy |
19,358,912
+586,973
| +3% | +$17.9M | 0.94% | 14 |
|
|
2016
Q3 | $603M | Sell |
18,771,939
-514,563
| -3% | -$17.2M | 0.97% | 13 |
|
|
2016
Q2 | $644M | Buy |
19,286,502
+1,489,091
| +8% | +$47.5M | 1.04% | 11 |
|
|
2016
Q1 | $480M | Buy |
17,797,411
+5,069,424
| +40% | +$145M | 0.88% | 14 |
|
|
2015
Q4 | $390M | Buy |
12,727,987
+170,643
| +1% | +$5.37M | 0.94% | 13 |
|
|
2015
Q3 | $374M | Buy |
12,557,344
+1,230,966
| +11% | +$39.5M | 0.96% | 11 |
|
|
2015
Q2 | $360M | Buy |
11,326,378
+254,014
| +2% | +$8.28M | 0.93% | 10 |
|
|
2015
Q1 | $365M | Buy |
11,072,364
+3,806,943
| +52% | +$121M | 0.98% | 9 |
|
|
2014
Q4 | $215M | Sell |
7,265,421
-256,228
| -3% | -$7.35M | 0.8% | 13 |
|
|
2014
Q3 | $211M | Sell |
7,521,649
-136,071
| -2% | -$3.82M | 0.81% | 15 |
|
|
2014
Q2 | $216M | Sell |
7,657,720
-54,281
| -0.7% | -$1.55M | 0.8% | 14 |
|
|
2014
Q1 | $235M | Sell |
7,712,001
-801,251
| -9% | -$23.9M | 0.92% | 12 |
|
|
2013
Q4 | $247M | Buy |
8,513,252
+573,692
| +7% | +$16.7M | 0.97% | 11 |
|
|
2013
Q3 | $216M | Sell |
7,939,560
-127,323
| -2% | -$3.46M | 0.9% | 12 |
|
|
2013
Q2 | $214M | Buy |
+8,066,883
| New | +$223M | 0.94% | 13 |
|
Other funds holding PFE
VCM
VPM
Swiss National Bank's PFE Position: Q1 2026 in Review
Swiss National Bank increased its Pfizer (PFE) stake by 7.1% in Q1 2026, buying an estimated $29.5M and bringing the position to 16,686,212 shares worth $469M. The position accounts for 0.27% of the portfolio, ranked #59.
Swiss National Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.28B in Q2 2022. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Swiss National Bank held 16,686,212 shares of Pfizer worth $469M as of Q1 2026.
- Swiss National Bank bought 1,106,200 Pfizer shares in Q1 2026, an estimated $29.5M.
- Pfizer made up 0.27% of Swiss National Bank's portfolio in Q1 2026, its #59 holding.
- Swiss National Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Swiss National Bank's Pfizer position peaked at $1.28B in Q2 2022.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.